ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ARWR is currently covered by 12 analysts with an average potential upside of $16.04 (50.61%) backed by displayed 119 price targets and 131 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.53% with an average time for these price targets to be met of 249.12 days.

Highest price target for ARWR is 54, Lowest price target is 26, average price target is 40.

Most recent stock forecast was given by LUCA ISSI from RBC on 30-Nov-2023. First documented stock forecast 18-Dec-2013.

Currently, out of the existing stock ratings of ARWR - 30 which are a Buy (81.08%), 7 which are a Hold (18.92%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

50

$21.02 (72.53%)

1 days ago

2/4 (50%)

$21.64 (52.25%)

100

Hold

33

$4.02 (13.87%)

90

2 months 12 days ago

2/3 (66.67%)

$9.48 (17.86%)

108

Buy

90

$63.13 (234.95%)

90

3 months 22 days ago

0/8 (0%)

$50.32 (143.58%)

Buy

60

3 months 23 days ago

3/10 (30%)

$22.46 (53.04%)

169

Buy

47

$18.02 (62.18%)

80

3 months 23 days ago

6/7 (85.71%)

$11.17 (35.86%)

436

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 249.12 days on average for the stock forecasts to be realized with a an average price target met ratio 65.53

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 3 price targets and 4 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Keay Nakae with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart